Friday, March 2, 2018

2nd Annual New Mexico Medical Cannabis Conference: Debra Kimless, M.D.


Presented by The Verdes Foundation
 at the National Hispanic Cultural Center
Sunday, March 4, 2018 10 am – 5 pm




2018 Conference Expert Profile: Dr. Debra Kimless 
- Anesthesiologist,
 Endocannabinoid System (ECS) Micro-Dosing Specialist,
 and Medical Cannabis Expert


When Regulators in Maryland issued the first license to grow medical cannabis in 2017, allowing a sprawling 2-acre warehouse in Anne Arundel County to immediately start cultivating medical cannabis.
The Maryland Medical Cannabis Commission voted unanimously to grant that first license to a company called ForwardGro, more than four years after the state first legalized the medicinal use of cannabis.
“A new industry in Maryland has been launched,” said Patrick Jameson, executive director of the commission. “They can start to grow immediately.”



Dr. Debra Kimless is the medical director for ForwardGro. She has spent the past three years to immersing herself in all aspects of medical cannabis, including scientific and medical applications for the treatment of patients. She has traveled the world studying under the most respected experts in cannabis medicine and science, most notably, in both the Netherlands and in Israel, two countries regarded as best practice models in the use of medical cannabis.

Debra Kimless, M.D. graduated magna cum laude from Muhlenberg College with a double major in Natural Sciences and Biology. She was selected to be part of Phi Beta Kappa honor society. She went on to medical school at Rutgers, and residency at Temple University Hospital where she studied and became a clinical practitioner for over 15 years as a boarded Anesthesiologist with a subspecialty certification in Pain Medicine.

Motivated by her mother who suffered horribly with intractable pain at the end of her life and who had always responded paradoxically to opiates, Dr. Kimless became a passionate champion for medical cannabis.




Dr. Kimless dedicated the last several years to immersing herself in all aspects of medical cannabis, including scientific and medical applications for the treatment of patients. She has traveled the world studying under the most respected experts in cannabis medicine and science, most notably, in both the Netherlands and in Israel (two countries regarded as best practice models in the use of medical cannabis).

She shares her knowledge by speaking with physicians to educate them about the endocannabinoid system and to help them understand how medical cannabis can be an effective tool to help patients. She also consults with patients pro bono to introduce cannabis medicine as a treatment option. She has first-hand experience in successfully treating patients with a variety of medical conditions using an individualized treatment plan. She collects patient data and has submitted case study abstracts for publication.

Her passion is to educate physicians, patients, and the public to de-stigmatize cannabis so they understand that is a real and effective medical therapeutic choice.

Thought Leaders In Cannabis: Dr. Debra Kimless - Medical Director of ForwardGro


ForwardGro has combined best in class greenhouse growing practices, business management, medical cannabis research, and patient advocacy to become one of Maryland’s premier growers of medical cannabis. The team understands the plant-related benefits of growing cannabis in an energy-efficient and sustainable greenhouse environment will result in the most consistent product possible.

While the medical value of cannabis is known, and accepted in many states, there are still many new uses and science-based opportunities yet to be determined. ForwardGro Medical Director, Dr. Deb Kimless, has been actively pursuing data through pro bono individualized treatments of patients suffering from a range of conditions including: epilepsy, arthritis, cancer and pain management. In states where medical cannabis is currently legal, she has assisted patients in developing tailored treatment plans using different methods of administration, and varying cannabinoid ratios to influence patient response. A specialist in the Endocannabinoid System (ECS), a signaling system that maintains physiological balance throughout the body, she’s demonstrated how cannabis treatments work with the ECS to treat pain and other medical conditions. Additional and ongoing research demonstrates the potential for cannabis-related treatments for disease and other medical conditions far beyond what is currently known. Dr Kimless is an internationally recognized speaker.



ForwardGro Patient Advocate, Gail Rand, who has a family member who suffers from epilepsy, became passionately involved in the Maryland legislature in 2013 as a parent advocate. She played an integral role in helping to pass the 2014 medical cannabis legislation in Maryland, as well as the 2015 legislation that further improved the program. She is the founder of a parental advocacy group for the legalization of medical cannabis in Maryland for children with epilepsy. Rand’s expertise working on behalf of patients, will help ensure that ForwardGro will bring high-quality medical cannabis to patients in need in the state of Maryland.

Visit ForwardGro's Website Here 


2018 CONFERENCE DETAILS Or Click Here

Don’t forget to bring the essentials for taking notes: Pens, Pencils, Paper, Notebook, Clipboard or Laptop.

Sunday, March 4, 2018 10 am – 5 pm
National Hispanic Cultural Center - Roy E. Disney Center for Performing Arts
Presented by the Verdes Foundation

Online Ticket Sales are Sold Out.

For Ticket Availability:
Call the Box Office at 505.724.4771 (Open till 5p Friday/Noon to 5p Saturday)

R. Greenleaf also has a limited number of tickets at (505) 217-9101

On Sunday March 4th :Registration 10:00 am; Conference 11:00 am – 5:00 pm
Lunch Break 1:00 pm. You can add a boxed lunch option when your purchase your ticket or enjoy lunch on your own.

FEATURING

HOW PATIENTS BENEFIT FROM MEDICAL CANNABIS
Presented by Bonni Goldstein, M.D.

NUTRITION, CANNABIS AND CANCER
Presented by Debra Kimless, M.D.

COMPARISON OF THE ANTI-TUMOR EFFICACY OF A WHOLE-PLANT EXTRACT VS. PURE THC IN PRECLINICAL MODELS OF HER2-POSITIVE BREAST CANCER
Presented by Mara Gordon

CANNABIS: A SOLUTION TO THE OPIOID EPIDEMIC?
Presented by Dr. Dustin Sulak


No comments:

Post a Comment